摘要
表观遗传学在基因调控和其他细胞过程中具有重要作用。 DNA甲基化作为表观遗传学的主要机制之一,是一种复制后修饰。异常的 DNA 甲基化可以改变基因表达模式;因此,它在许多疾病的发病机制中起着相当大的作用。特定基因启动子中的 DNA 甲基化改变可用于诊断和专有靶标充当“生物标志物”。由于这些生物标志物,早期诊断和预防是可能的。根据最近的研究,DNA甲基化异常在视网膜疾病的视网膜形成和发病机制中具有重要作用。视网膜疾病是世界范围内导致失明和严重视力丧失的主要原因,而且还会继续增加。此外,它们还给社会和医疗保健系统带来了巨大的负担。因此,重点关注更好地识别和预防视网膜疾病,寻找新的治疗靶点非常重要。由于其可逆性,DNA 甲基化被视为有吸引力的治疗靶点。表观遗传疗法在治疗视网膜疾病方面具有很高的效力。在这里,我们回顾了常见视网膜疾病中的 DNA 和组蛋白甲基化改变,重点关注年龄相关性黄斑变性 (AMD)、糖尿病性视网膜病变、视网膜脱离 (RD)、色素性视网膜炎、视网膜老化和视网膜母细胞瘤。然后我们调查了一些新的视网膜疾病表观遗传治疗方法。
关键词: DNA 甲基化、表观遗传学、基因表达、超甲基化、视网膜疾病、视网膜生成。
Current Molecular Medicine
Title:A Review of DNA and Histone Methylation Alterations in the New Era of Diagnosis and Treatment of Retinal Diseases
Volume: 21 Issue: 8
关键词: DNA 甲基化、表观遗传学、基因表达、超甲基化、视网膜疾病、视网膜生成。
摘要: Epigenetics has an important role in gene regulation and other cellular processes. DNA methylation, as one of the main mechanisms of epigenetics, is a type of post-replication modifications. Aberrant DNA methylation can alter gene expression patterns; so, it plays a considerable role in the pathogenesis of many diseases. DNA methylated alterations in the promoter of specific genes can be used for the diagnosis and proprietary targets acting as a “biomarker”. Early diagnosis and prevention may be possible due to these biomarkers. According to recent studies, DNA methylation abnormalities have an important role in the retinogenesis and pathogenesis of retinal diseases. Retinal diseases are the main cause of blindness and severe vision loss in the world, which will continue to increase. Also, they inflict an enormous burden on society and health care systems. Therefore, it is important to focus on the better recognition and prevention of retinal diseases and finding new targets for the treatment. DNA methylation is lionized as attractive therapeutic targets due to its reversibility. Epigenetic therapy has a high potency in the treatment of retinal diseases. Here, we reviewed the DNA and histone methylation alterations in common retinal diseases, focusing on agerelated macular degeneration (AMD), diabetic retinopathy, retinal detachment (RD), retinitis pigmentosa, retinal aging, and retinoblastoma. Then we surveyed some new approaches to epigenetic therapy in retinal disorders.
Export Options
About this article
Cite this article as:
A Review of DNA and Histone Methylation Alterations in the New Era of Diagnosis and Treatment of Retinal Diseases, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/1566524020666201209103603
DOI https://dx.doi.org/10.2174/1566524020666201209103603 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fungal Proteins with Antiproliferative and Anticancer Activities
Protein & Peptide Letters High Throughput Determination of Gains and Losses of Genetic Material Using High Resolution BAC Arrays and Comparative Genomic Hybridization
Combinatorial Chemistry & High Throughput Screening Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
Current Pharmaceutical Design Chemotherapy and Target Therapy in the Management of Adult High- Grade Gliomas
Current Cancer Drug Targets New Strategies and Patent Therapeutics in EBV-Associated Diseases
Mini-Reviews in Medicinal Chemistry A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Altering the Sphingosine-1-Phosphate/Ceramide Balance: A Promising Approach for Tumor Therapy
Current Pharmaceutical Design Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)
Current Pharmaceutical Design Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design Cancer Metastasis as Disrupted Developmental Phenotype
Current Genomics Tumor-Targeted Inhibition by a Novel Strategy - Mimoretrovirus Expressing siRNA Targeting the Pokemon Gene
Current Cancer Drug Targets PEDF and Septic Shock
Current Molecular Medicine Subject Index To Volume 8
Current Pharmaceutical Design Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Current Medicinal Chemistry Lymphocytes in Alzheimer’s Disease Pathology: Altered Signaling Pathways
Current Alzheimer Research Stem Cell Function, Self-Renewal, Heterogeneity, and Regenerative Potential in Skeletal Muscle Stem Cells
Recent Patents on Regenerative Medicine Virus-based Gene Transfer Approaches and Adipose Tissue Biology
Current Gene Therapy